CHR — Chr Hansen Holding A/S Share News
0.000.00%
Last trade - 00:00- DKK73.91bn
- DKK80.85bn
- €1.33bn
Brief: Danone Launches Partnerships Program To Enable 'Renew Danone'
Brief: Novozymes And Chr. Hansen: Chinese Merger Approval Granted
Enzymes maker Novozymes' Q2 profit drops more than expected (updated)
Novozymes' Q2 operating profit lags expectations
Brief: Chr. Hansen Adjusts Outlook For Organic Growth, Outlook For EBIT Margin Maintained
Brief: Chr. Hansen Q3 Adjusted EBIT Slightly Below Estimates
Novozymes first-quarter results beats forecast (updated)
Novozymes Q1 beats forecast
Europe Research Roundup: BMW, Mercedes Benz Group, Swedbank
Brief: Chr. Hansen Sees 2022/2023 Organic Revenue Growth At 8-11%
Brief: Chr. Hansen Q2 Earnings Top Consensus
Brief: Novozymes Shareholders Approve Combination With Chr. Hansen
Brief: Chr Hansen Holding Updates On Combination Of Novozymes, Chr. Hansen
Brief: Chr. Hansen Started Seeking Regulatory Approvals On Novozymes Merger
Brief: Chr. Hansen Q1 Adj. EBIT Slightly Below Consensus
Europe Research Roundup: AstraZeneca, Next, Standard Chartered
Street View: Analysts question Novozymes, Chr Hansen merger synergies
Refinitiv Newscasts - BVTV: Pricey Danish enzymes
Danish $22 bln enzyme M&A is costly bet on growth